Xapien has raised a $56 million growth round led by Spectrum Equity, with existing backer YFM Equity Partners also putting in money. The company builds an AI system that scans the open web, corporate filings, sanctions lists, and media coverage across languages to produce due-diligence reports on counterparties for banks, law firms, and compliance teams, in what it says is minutes rather than days. It plans to use the cash to grow further in the U.S., already about half its revenue, including expanding its Boston office and relocating its CEO and other leadership there, a bet that the largest addressable market for AI due diligence sits closer to Wall Street than the City of London.

The growth number in the release is the one worth sitting with: Xapien says annual recurring revenue is up more than 350% over the past 24 months. The company serves 350 clients and partners across 15 countries, with names like Greenberg Traurig, ABB, Dow Jones Risk & Compliance, and KPMG attached, in the same compliance-software category as other CRM and workflow tools banks are adopting. It claims clients can fully automate 90% of onboarding due-diligence cases, which is the kind of number that sounds impressive until you ask which 90%, since the easy, low-risk cases are exactly the ones you’d expect a tool like this to clear without a human.

Founder and CEO Chris Green, who started the company in 2018 with Dan Secretan and Shaun O’Mahony, all veterans of BAE Systems’ financial crime and national security work, said the funding is meant to give compliance and procurement teams constant visibility into every counterparty they deal with, rather than the periodic snapshot a traditional due-diligence report provides.

Why Xapien’s Spectrum Equity Backing Matters

Spectrum Equity’s involvement is the more interesting signal than the round size itself. The firm has spent two decades in risk and compliance technology and previously backed World-Check and Verafin, both of which became foundational infrastructure in AML and sanctions screening before being acquired by larger players (Refinitiv and Nasdaq, respectively). That’s not a random check writer. It’s a firm that has watched this category consolidate before and is betting Xapien becomes one of the next names bought rather than building, which says something about where Spectrum thinks this business ends up in a few years.

Fifty-six million dollars is a real number but not a category-defining one in a compliance-tech market that already includes bigger, better-capitalized players doing overlapping work in KYC and counterparty risk. What separates Xapien from a standard KYC vendor is the “open web plus multilingual media” angle rather than just structured databases and sanctions lists, which is a genuinely harder problem to do well and a more defensible moat if the retrieval quality holds up at scale.

The 350% ARR growth claim, if real, suggests law firms and banks are already finding that useful enough to pay for. Whether that holds once the company is selling to larger, slower-moving enterprise compliance departments instead of early adopters is the actual test. Enterprise procurement cycles at global banks run on a different clock than the law firms and mid-market compliance teams Xapien has signed so far, and that transition is where growth-stage due-diligence vendors most often stall, and it is the real test of whether this round was raised a year too early or right on time.

The U.S. push under a Boston-based leadership team is the thing to track next, specifically whether Xapien lands a marquee U.S. bank client rather than just law firms and consultancies, which would be the clearer signal that it’s ready to compete for enterprise compliance budgets rather than niche legal ones.